Summary

● In view of fundamental criteria, the company is among low performers as far as mid or long-term investment strategy is concerned.

● In a short-term perspective, the company has interesting fundamentals.


Strengths

● For the last week, the earnings per share forecast has been revised upwards. According to recent estimates, analysts give a positive overview of the stock

● For several months, analysts have been revising their EPS estimates roughly upwards.

● The stock is in a well-established, long-term rising trend above the technical support level at 3.88 USD


Weaknesses

● Stock prices approach a strong long-term resistance in weekly data at USD 6.59.

● As estimated by analysts, this group is among those businesses with the lowest growth prospects.

● Low profitability weakens the company.

● One of the major weak points of the company is its financial situation.

● Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.

● Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.

● The firm trades with high earnings multiples: 39.6 times its 2020 earnings per share.

● The company is not the most generous with respect to shareholders' compensation.

● For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.

● For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.

● Most analysts agree on a negative opinion with regard to the stock. Indeed, the average consensus issues recommendations to underperform or sell.

● The three month average target prices set by analysts do not offer high potential in comparison with the current prices.